Mendota Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13
Closed -$4.05K 101
2025
Q1
$4.05K Buy
+13
New +$3.84K ﹤0.01% 94
2024
Q4
Sell
-1
Closed -$323 420
2024
Q3
$323 Buy
+1
New +$327 ﹤0.01% 463
2023
Q4
Sell
-14
Closed -$3.76K 376
2023
Q3
$3.76K Hold
14
﹤0.01% 234
2023
Q2
$3.11K Sell
14
-264
-95% -$61.3K ﹤0.01% 234
2023
Q1
$67.2K Buy
278
+250
+893% +$61.4K 0.07% 124
2022
Q4
$7.35K Buy
+28
New +$7.51K 0.01% 218

Other funds holding AMGN

Mendota Financial Group's AMGN Position: Q2 2025 in Review

Mendota Financial Group sold out of Amgen (AMGN) in Q2 2025, closing a stake of 13 shares — an estimated $4.05K sold.

Mendota Financial Group first reported a position in AMGN in Q4 2022 and held it in 6 quarters. The position peaked at $67.2K in Q1 2023. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Mendota Financial Group reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Mendota Financial Group sold 13 Amgen shares in Q2 2025, an estimated $4.05K.
  • Mendota Financial Group first reported a position in Amgen in Q4 2022 and held it in 6 quarters.
  • Mendota Financial Group's Amgen position peaked at $67.2K in Q1 2023.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Mendota Financial Group's 13F filing for Q2 2025, filed 21 Jul 2025.